Results

Total Results: 2,337 records

Showing results for "responses".

721. Template for Reports Developed (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - Template for Reports Developed Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Identification o…

722. Data-Points-6-Tables (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables.xls
     January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …

723. McCullough (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/mccullough.pdf
     January 01, 2011 - management: clinical ethical tool for responsibly managing uncertainty about plan of care o Candor-­‐based responses

724. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

725. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
     July 16, 2018 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

726. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses

727. Gene Expression Profiling for Predicting Outcomes in Patients With Stage II Colon Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
     March 13, 2012 - and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses

728. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - significant improvement in American College of Rheumatology criteria for 20% improvement (ACR20) responses … 66.3%, and 32.6%, and patients whose symptoms did not respond to previous TNF treatment had ASAS20 responses … patients who received secukinumab 75 mg did not have significant improvements in ASAS20 or ASAS40 responses … Using an observed analysis, patients treated with secukinumab 75 mg had ACR 20/50/70 responses of 66.9%

729. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - Comments on draft reviews and the authors’ responses to the comments will be posted publicly on the

730. The purpose of our tool is to compile a comprehensive list of questions that may be used to evaluate the quality of non-randomized studies of interventions or exposures (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/reliability-testing-grading-evidence_research.pdf
     May 01, 2012 - completed each of the exercises; subsequently, each pair of reviewers reconciled their independent responses … the 10 exercises; subsequently, the two reviewers—i.e., the ―pair‖—reconciled their independent responses … We assigned a numeric value to each of the domains/strength of evidence responses for each reviewer … Agreement improved to fair (AC1=0.22) among pairs of reviewers for the reconciled responses. … Reconciliation Across Reviewer Pairs We received responses from 8 of the 11 pairs describing the approach

731. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

732. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
     November 01, 2013 - surveys or focus groups, which generally obtain more top-of-mind—that is, initial and more intuitive—responses … Finally, responses to the question would elicit the public’s values around whether patients and physicians … The panelists’ responses were played back to participants during the third session and served as a basis … • When presented with the deliberative question, many participants’ initial responses showed that

733. Vaginal Birth After Cesarean: Developing and Prioritizing a Future Research Agenda (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
     August 09, 2012 - Phase 2, Delphi Round 1: Detailed Responses ......................................................... … They were instructed not to rank the five lowest priority topics. round 2 responses were weighted so … Phase 2, Delphi round 1: detailed responses Question a High (%) (n) Medium (%) (n) Low (% … Phase 2, Delphi round 1: detailed responses (continued) Question a High (%) (n) Medium (%) (n) … Phase 2, Delphi round 1: detailed responses (continued) Question a High (%) (n) Medium (%) (n)

734. Hit-Patient-Care Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
     June 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

735. Delilberative-Methods-Design-Carman (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/delilberative-methods-design-carman.pdf
     June 01, 2012 - Slide 30 Deliberative Methods Experiment Agency for Healthcare Research and Quality Community Forum Slide 31 Background & objectives of experiment  Background o Started in August 2010 o Literature review, Technical Expert Panel, formative research to inform approach  Objectives o Expand the …

736. Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-interventions-future_research.pdf
     September 01, 2012 - We reviewed stakeholder responses from the teleconference call and snowball survey, and developed a … related to therapies for adolescents and young adults with ASD after reviewing the teleconference responses … We reviewed stakeholder responses from the teleconference call and snowball survey, and developed a … We reviewed the stakeholder responses and developed a comprehensive list of research questions related … to therapies for adolescents and young adults with ASD after reviewing the teleconference responses

737. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

738. Stereotactic Body Radiation Therapy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stereotactic-body-radiation/technical-brief
     May 02, 2011 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

739. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - risk of bias) that used PK/PD measures to study the impact of different antibiotic dosing on clinical responses

740. • Identify disparities and reasons for disparities and reevaluate the framework for researching disparities The following article was used in answering this question: Davis, L. M., Kilburn, M. R., and Schultz, D. (2009). Reparable Harm:… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/identify-disparities-and-reasons-for-disparities-and-reevaluate-the-framework-for-researching-disparities-the-following-article-was-used-in-answering-this-question-davis-l-m-kilburn-m-r-and-schultz-d-2009-reparable-harm-asse
     November 23, 2010 - subgroups of patients (e.g., age, race, and common comorbidities) to identify variation in patient responses